Literature DB >> 26142081

Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1—Psychometric Characteristics of 5 Paradigms.

L Felice Reddy1, William P Horan2, Deanna M Barch3, Robert W Buchanan4, Eduardo Dunayevich5, James M Gold4, Naomi Lyons6, Stephen R Marder2, Michael T Treadway7, Jonathan K Wynn2, Jared W Young8, Michael F Green2.   

Abstract

Impairments in willingness to exert effort contribute to the motivational deficits characteristic of the negative symptoms of schizophrenia. The current study evaluated the psychometric properties of 5 new or adapted paradigms to determine their suitability for use in clinical trials of schizophrenia. This study included 94 clinically stable participants with schizophrenia and 40 healthy controls. The effort-based decision-making battery was administered twice to the schizophrenia group (baseline, 4-week retest) and once to the control group. The 5 paradigms included 1 that assesses cognitive effort, 1 perceptual effort, and 3 that assess physical effort. Each paradigm was evaluated on (1) patient vs healthy control group differences, (2) test-retest reliability, (3) utility as a repeated measure (ie, practice effects), and (4) tolerability. The 5 paradigms showed varying psychometric strengths and weaknesses. The Effort Expenditure for Rewards Task showed the best reliability and utility as a repeated measure, while the Grip Effort Task had significant patient-control group differences, and superior tolerability and administration duration. The other paradigms showed weaker psychometric characteristics in their current forms. These findings highlight challenges in adapting effort and motivation paradigms for use in clinical trials. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center 2015.

Entities:  

Keywords:  effort; motivation; psychometric; schizophrenia

Mesh:

Year:  2015        PMID: 26142081      PMCID: PMC4535649          DOI: 10.1093/schbul/sbv089

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  29 in total

1.  Cognitive effort avoidance and detection in people with schizophrenia.

Authors:  James M Gold; Wouter Kool; Matthew M Botvinick; Leeka Hubzin; Sharon August; James A Waltz
Journal:  Cogn Affect Behav Neurosci       Date:  2015-03       Impact factor: 3.282

2.  The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation.

Authors:  S R Kay; L A Opler; J P Lindenmayer
Journal:  Br J Psychiatry Suppl       Date:  1989-11

Review 3.  The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry.

Authors:  T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2002-08-09       Impact factor: 4.530

4.  The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.

Authors:  S R Marder; J M Davis; G Chouinard
Journal:  J Clin Psychiatry       Date:  1997-12       Impact factor: 4.384

Review 5.  Translational Rodent Paradigms to Investigate Neuromechanisms Underlying Behaviors Relevant to Amotivation and Altered Reward Processing in Schizophrenia.

Authors:  Jared W Young; Athina Markou
Journal:  Schizophr Bull       Date:  2015-07-20       Impact factor: 9.306

Review 6.  Effort-Based Decision Making: A Novel Approach for Assessing Motivation in Schizophrenia.

Authors:  Michael F Green; William P Horan; Deanna M Barch; James M Gold
Journal:  Schizophr Bull       Date:  2015-06-18       Impact factor: 9.306

7.  Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 2—External Validity and Correlates.

Authors:  William P Horan; L Felice Reddy; Deanna M Barch; Robert W Buchanan; Eduardo Dunayevich; James M Gold; Steven R Marder; Jonathan K Wynn; Jared W Young; Michael F Green
Journal:  Schizophr Bull       Date:  2015-07-23       Impact factor: 9.306

Review 8.  Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria.

Authors:  Michael F Green; Keith H Nuechterlein; James M Gold; Deanna M Barch; Jonathan Cohen; Susan Essock; Wayne S Fenton; Fred Frese; Terry E Goldberg; Robert K Heaton; Richard S E Keefe; Robert S Kern; Helena Kraemer; Ellen Stover; Daniel R Weinberger; Steven Zalcman; Stephen R Marder
Journal:  Biol Psychiatry       Date:  2004-09-01       Impact factor: 13.382

9.  Apathy but not diminished expression in schizophrenia is associated with discounting of monetary rewards by physical effort.

Authors:  Matthias N Hartmann; Oliver M Hager; Anna V Reimann; Justin R Chumbley; Matthias Kirschner; Erich Seifritz; Philippe N Tobler; Stefan Kaiser
Journal:  Schizophr Bull       Date:  2014-07-22       Impact factor: 9.306

10.  Validation of the 16-item Negative Symptom Assessment.

Authors:  B N Axelrod; R S Goldman; L D Alphs
Journal:  J Psychiatr Res       Date:  1993 Jul-Sep       Impact factor: 4.791

View more
  47 in total

1.  Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions.

Authors:  Samantha E Yohn; Daniela Alberati; Merce Correa; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2017-01-12       Impact factor: 4.530

2.  Methylphenidate increases willingness to perform effort in adults with ADHD.

Authors:  Merideth A Addicott; Julia C Schechter; Jeffrey J Sapyta; James P Selig; Scott H Kollins; Margaret D Weiss
Journal:  Pharmacol Biochem Behav       Date:  2019-06-18       Impact factor: 3.533

3.  Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: A meta-analysis.

Authors:  Lauren Luther; Melanie W Fischer; Ruth L Firmin; Michelle P Salyers
Journal:  Schizophr Res       Date:  2018-12-19       Impact factor: 4.939

4.  The current conceptualization of negative symptoms in schizophrenia.

Authors:  Stephen R Marder; Silvana Galderisi
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

5.  From neuroimaging to daily functioning: A multimethod analysis of reward anticipation in people with schizophrenia.

Authors:  Erin K Moran; Adam J Culbreth; Sridhar Kandala; Deanna M Barch
Journal:  J Abnorm Psychol       Date:  2019-08-29

6.  Preliminary support for the role of reward relevant effort and chronotype in the depression/insomnia comorbidity.

Authors:  Elaine M Boland; Kassondra Bertulis; Shirley H Leong; Michael E Thase; Philip R Gehrman
Journal:  J Affect Disord       Date:  2018-08-15       Impact factor: 4.839

Review 7.  Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.

Authors:  Jennifer C Felger; Michael T Treadway
Journal:  Neuropsychopharmacology       Date:  2016-08-02       Impact factor: 7.853

8.  Social motivation in schizophrenia: The impact of oxytocin on vigor in the context of social and nonsocial reinforcement.

Authors:  Daniel Fulford; Michael Treadway; Joshua Woolley
Journal:  J Abnorm Psychol       Date:  2018-01

Review 9.  A meta-analytic review of self-reported, clinician-rated, and performance-based motivation measures in schizophrenia: Are we measuring the same "stuff"?

Authors:  Lauren Luther; Ruth L Firmin; Paul H Lysaker; Kyle S Minor; Michelle P Salyers
Journal:  Clin Psychol Rev       Date:  2018-04-07

10.  Self-assessment of social cognitive ability in individuals with schizophrenia: Appraising task difficulty and allocation of effort.

Authors:  Danielle Cornacchio; Amy E Pinkham; David L Penn; Philip D Harvey
Journal:  Schizophr Res       Date:  2016-09-29       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.